Publicacións nas que colabora con MANUEL CAMPOS TOIMIL (12)

2022

  1. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

    ChemMedChem, Vol. 17, Núm. 21

2021

  1. Crambescin C1 Acts as A Possible Substrate of iNOS and eNOS Increasing Nitric Oxide Production and Inducing In Vivo Hypotensive Effect

    Frontiers in Pharmacology, Vol. 12

2020

  1. An Update to Calcium Binding Proteins

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 183-213

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

2018

  1. Sildenafil (Viagra®) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE -/- Mice

    Cellular Physiology and Biochemistry, Vol. 44, Núm. 5, pp. 1796-1809

2016

  1. Activation of PKA and Epac proteins by cyclic AMP depletes intracellular calcium stores and reduces calcium availability for vasoconstriction

    Life Sciences, Vol. 155, pp. 102-109

  2. Involvement of endothelium in the vasorelaxant effects of 3,4-DHPEA-EA and 3,4-DHPEA-EDA, two major functional bioactives in olive oil

    Journal of Functional Foods, Vol. 23, pp. 637-646

2012

  1. Calcium binding proteins

    Advances in Experimental Medicine and Biology, Vol. 740, pp. 461-482

1994

  1. Effects of hydralazine on contractile responses to α1 and α2-adrenoceptor agonists in isolated rubbed rat aorta

    General Pharmacology, Vol. 25, Núm. 1, pp. 165-172

  2. Pharmacological study of several effects of hydralazine in the bisected rat vas deferens

    European Journal of Pharmacology, Vol. 251, Núm. 1, pp. 83-90

1992

  1. Effect of urethane on hydralazine-induced tachycardia in rats

    General Pharmacology, Vol. 23, Núm. 6, pp. 1143-1147

  2. Role of the endothelial system in BAY K 8644 enantiomer and nifedipine vasomodulator action in rat aorta

    European Journal of Pharmacology, Vol. 221, Núm. 1, pp. 1-8